Chemed Increases Earnings Guidance - Quick Facts

(RTTNews) - Chemed Corp. (CHE) announced, full-year 2017 adjusted earnings per diluted share, excluding non-cash expense for stock options, costs related to litigation, and other discrete items, is now estimated to be in the range of $8.10 to $8.20. Roto-Rooter is forecasted to achieve full-year 2017 revenue growth of 12% to 13%. Revenue growth for VITAS in 2017, prior to Medicare Cap, is estimated to be in the range of 2% to 3%.

Second-quarter adjusted EPS increased 19.4% to $2.15. GAAP Loss-per-share was $1.35 which included $3.49 for potential litigation settlement. Revenue increased 6.3% to $415 million.